Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease

Launched by JOSE SEIJAS AMIGO · May 14, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥18 years
• • 2. Prior diagnosis of chronic coronary disease
• At least one of the following:
• • 1. Type 2 diabetes mellitus
• • 2. Familial hypercholesterolemia
• • 3. Recurrent coronary disease
• • 4. Chronic kidney disease
• 3. Currently undergoing pharmacological treatment with high-potency statins, with or without ezetimibe. The allowed statins and daily doses are:
• • 1. Atorvastatin 80mg
• • 2. Rosuvastatin 20mg
• • 3. Rosuvastatin 40mg
• • 4. Patients on other statins or lower doses are acceptable if there has been documented intolerance to the specified molecules and doses.
• • 4. Blood analysis with a lipid profile in the last 6 months and with the current treatment showing LDL levels \>100mg/dl.
• Exclusion Criteria:
• • 1. Not receiving statins in the therapeutic regimen.
• • 2. Concomitant treatment with PCSK9 inhibitors.
• • 3. Pregnancy, breastfeeding, or a desire to conceive by the patient.
• • 4. Patients who, in the opinion of the investigator, are unable to adequately follow up in the chronic care program under routine clinical practice.